Mucins in pancreatic cancer: A well‐established but promising family for diagnosis, prognosis and therapy-Reference-Cited by-同舟云学术

Mucins in pancreatic cancer: A well‐established but promising family for diagnosis, prognosis and therapy

Published:2020-08-03 Issue:18 Volume:24 Page:10279-10289
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Wang Shunda¹^ORCID,You Lei¹,Dai Menghua¹,Zhao Yupei¹

Affiliation:

1. Department of General Surgery Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.15684

Reference129 articles.

1. Cancer statistics, 2019

2. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

3. Pancreatic cancer incidence and mortality patterns in China, 2011;He Y;Chin J Cancer Res,2015

4. New biomarkers and targets in pancreatic cancer and their application to treatment

5. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance;Andrianifahanana M;Clin Cancer Res,2001

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Potential Biomarkers associated with Prognosis and Pathogenesis of Pancreatic Cancer;2023-12-08

2. Pancreatic ductal adenocarcinoma with acinar-to-ductal metaplasia-like cancer cells shows increased cellular proliferation;Pancreatology;2023-11

3. Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinoma;Communications Medicine;2023-10-19

4. MUC16 C terminal fragment activates YAP1 through Src signaling to promote gallbladder cancer growth;MedComm – Oncology;2023-10-17

5. Immune checkpoint inhibitor‐related molecular markers predict prognosis in extrahepatic cholangiocarcinoma;Cancer Medicine;2023-10